Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection.
Saved in:
| Title: | Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection. |
|---|---|
| Authors: | Canini L; Program for Experimental and Theoretical Modeling Division of Hepatology, Loyola University Medical Center Maywood IL.; Centre for Immunity Infection and Evolution, University of Edinburgh Edinburgh United Kingdom., Koh C; Translational Hepatology Unit Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda MD., Cotler SJ; Program for Experimental and Theoretical Modeling Division of Hepatology, Loyola University Medical Center Maywood IL., Uprichard SL; Program for Experimental and Theoretical Modeling Division of Hepatology, Loyola University Medical Center Maywood IL., Winters MA; Department of Medicine Division of Gastroenterology and Hepatology and Department of Microbiology and Immunology, Stanford School of Medicine Stanford CA., Han MAT; Translational Hepatology Unit Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda MD., Kleiner DE; Laboratory of Pathology National Cancer Institute, National Institutes of Health Bethesda MD., Idilman R; Department of Gastroenterology Ankara University Ankara Turkey., Yurdaydin C; Department of Gastroenterology Ankara University Ankara Turkey., Glenn JS; Department of Medicine Division of Gastroenterology and Hepatology and Department of Microbiology and Immunology, Stanford School of Medicine Stanford CA., Heller T; Translational Hepatology Unit Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health Bethesda MD., Dahari H; Program for Experimental and Theoretical Modeling Division of Hepatology, Loyola University Medical Center Maywood IL. |
| Source: | Hepatology communications [Hepatol Commun] 2017 May 19; Vol. 1 (4), pp. 288-292. Date of Electronic Publication: 2017 May 19 (Print Publication: 2017). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 101695860 Publication Model: eCollection Cited Medium: Internet ISSN: 2471-254X (Electronic) Linking ISSN: 2471254X NLM ISO Abbreviation: Hepatol Commun Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
